Actively Recruiting
Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy
Led by Christian Ophthalmic Surgery Expedition Network · Updated on 2025-03-28
150
Participants Needed
1
Research Sites
113 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients undergoing surgery for complications related to diabetes will be recruited.
CONDITIONS
Official Title
Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject age is > 18
- Subject consents to study participation and can complete 6 months of follow-up
- Type I or II Diabetes Mellitus with active Proliferative Diabetic Retinopathy in the study eye
- Best-corrected visual acuity in the study eye ranges from 20/40 to Hand Motions
- Need for pars plana vitrectomy due to non-clearing vitreous hemorrhage (present at least 3 months), threatening or fovea-involving tractional retinal detachment, or extensive fibrovascular proliferation (>3 clock hours) threatening or involving the fovea
- Only one eye per patient is eligible for the study
You will not qualify if you...
- Significant retinal or optic nerve disease unrelated to diabetes causing two or more lines of vision loss in the study eye (e.g., macular degeneration, optic neuritis, glaucoma, amblyopia)
- Significant corneal opacity causing two or more lines of vision loss in the study eye (e.g., corneal scar, ectasia)
- Previous vitrectomy surgery in the study eye
- Uncontrolled neovascular glaucoma with intraocular pressure > 30 mmHg despite treatment in the study eye
- Uncontrolled hypertension with systolic > 200 mmHg or diastolic > 120 mmHg despite multiple medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sky Vision
Querétaro City, Querétaro, Mexico, 76165
Actively Recruiting
Research Team
R
Ryan Rush, MD
CONTACT
C
Christi Rush
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here